Literature DB >> 16298166

Recurrent urinary tract infections.

Anna Virginia M Franco1.   

Abstract

Urinary tract infection (UTI) is one of the most common bacterial infections in women, and one in four of these women will develop a recurrence. Various risk factors predispose women of different age groups to recurrence. These factors include sexual intercourse, use of contraception, antimicrobials, oestrogen, genetics, and the distance of the urethra from the anus. Of the different pathogens, Escherichia coli is the organism most commonly isolated. A variety of treatment options has been proposed, including long-term or post-intercourse prophylaxis and patient-initiated therapy. Oestrogen and cranberry juice have also been used as prophylactic treatment adjuncts. At present, other therapeutic and preventive modalities are being investigated, including the development of vaccines to treat those most severely affected.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16298166     DOI: 10.1016/j.bpobgyn.2005.08.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  18 in total

1.  Recurrent urinary tract infections in women with symptoms of pelvic floor dysfunction.

Authors:  Bernard T Haylen; Joseph Lee; Sue Husselbee; Matthew Law; Jialun Zhou
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-03-17

Review 2.  Chinese herbal medicine for treating recurrent urinary tract infections in women.

Authors:  Andrew Flower; Li-Qiong Wang; George Lewith; Jian Ping Liu; Qing Li
Journal:  Cochrane Database Syst Rev       Date:  2015-06-04

3.  How women manage recurrent urinary tract infections: an analysis of postings on a popular web forum.

Authors:  Andrew Flower; Felicity L Bishop; George Lewith
Journal:  BMC Fam Pract       Date:  2014-09-26       Impact factor: 2.497

4.  Recurrent Urinary Tract Infections Management in Women: A review.

Authors:  Ahmed Al-Badr; Ghadeer Al-Shaikh
Journal:  Sultan Qaboos Univ Med J       Date:  2013-06-25

5.  Urinary excretion of ciprofloxacin after administration of extended release tablets in healthy volunteers. Swellable drug-polyelectrolyte matrix versus bilayer tablets.

Authors:  M L Guzmán; C B Romañuk; M F Sanchez; L C Luciani Giacobbe; L P Alarcón-Ramirez; F D Battistini; F L Alovero; A F Jimenez-Kairuz; R H Manzo; María Eugenia Olivera
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

Review 6.  Waging war against uropathogenic Escherichia coli: winning back the urinary tract.

Authors:  Kelsey E Sivick; Harry L T Mobley
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

Review 7.  Recurrent urinary tract infections in women.

Authors:  Abdullatif Aydin; Kamran Ahmed; Iftikhar Zaman; Muhammad Shamim Khan; Prokar Dasgupta
Journal:  Int Urogynecol J       Date:  2014-11-20       Impact factor: 2.894

8.  Vaginal mucosal vaccine for recurrent urinary tract infections.

Authors:  Gagan Gautam; Rakesh Khera
Journal:  Indian J Urol       Date:  2007-07

9.  Modelling the dynamics of intramammary E. coli infections in dairy cows: understanding mechanisms that distinguish transient from persistent infections.

Authors:  Lisa J White; Ynte H Schukken; Belgin Dogan; Laura Green; Dörte Döpfer; Mike J Chappell; Graham F Medley
Journal:  Vet Res       Date:  2009-10-20       Impact factor: 3.683

Review 10.  Pelvic Organ Prolapse-Associated Cystitis.

Authors:  Rizwan Hamid; Giovanni Losco
Journal:  Curr Bladder Dysfunct Rep       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.